HOVILPRI
LIVE

Serial Number

79372254

Owner

AIC316 GmbH

Attorney

F. William McLaughlin

Filing Date

Mar 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

HOVILPRI Trademark

Serial Number: 79372254 • Registration: 7539866

HOVILPRI is a trademark filed by AIC316 GmbH on March 23, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

AIC316 GmbH (7 trademarks)

Friedrich-Ebert-Str. 475

Entity Type: 98

Trademark Details

Filing Date

March 23, 2023

Registration Date

October 22, 2024

Published for Opposition

August 6, 2024

Goods & Services

Medical devices for intra-vaginal use for treatment of infectious diseases, viral infections, herpes simplex virus infections; Medical devices for intra-vaginal use for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; medical devices for intra-vaginal application of anti-virals; medical devices for intra-vaginal application of sulfonamides

Pharmaceutical consultancy services; consultancy and information services relating to medical products; providing health information; information services relating to health care; provision of health information; medical information services provided via the internet

Organization of seminars and conventions in the field of medicine; Publication of scientific information journals; publishing of online electronic publications; publishing of electronic publications; providing education courses in the field of science; Organization of seminars and conventions in the field of virology.

Antivirals; antivirals for topical use; Medicine for treatment of infectious diseases, viral infections, herpes simplex virus infections, Medicine for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Medicines for treatment of infectious diseases, viral infections, herpes simplex virus infections for human purposes, Medicines for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections for human purposes; Medicines for treatment of viral infections for veterinary purposes; Medicines for dental purposes; medicated eye lotions for medical use; medicated eye ointment for medical use; Creams for dermatological use; Dermatological-pharmaceutical products; Medicated lip creams; Medicated skin creams; Medicated skin lotions; Medicinal preparations for the treatment of infectious diseases; Medicated ointments for application to the skin for treating dermatological conditions; Medicated preparations for treating dermatological conditions; Medicated ointments for treating dermatological conditions; medicated preparations for the treatment of herpes of the lips; Ophthalmological preparations; Ophthalmic preparations; Ophthalmologic preparations; Pharmaceutical preparations for ophthalmological use; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical products for ophthalmological use; Topical ophthalmic anti-infective substances for the treatment of infections; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical lip ointments; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for use in gynecology; Pharmaceutical preparations and substances for use in urology; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of diseases of the genitourinary system; Pharmaceutical preparations for the prevention of diseases of the genitourinary system; Pharmaceutical preparations for skin wounds; Sulfonamides being medicines; Sulfonamide preparations; Transdermal patches for medical treatment of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical lipsalves; Antiviral drugs for treating herpes simplex virus infections; Preparations for the treatment of genital herpes; Medicinal preparations for the treatment of herpes simplex virus infections; medicinal preparations for the treatment of labial herpes; medicinal preparations for the treatment of mucosal herpes; Pharmaceutical preparations for the treatment of herpes simplex virus infections; Pharmaceutical preparations for skin lesions; Sulfonamides for treatment of infectious diseases, viral infections, herpes simplex virus infections, Sulfonamides for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections, Salts of sulfonamides for treatment of infectious diseases, viral infections, herpes simplex virus infections, Salts of sulfonamides for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations in the form of tablets for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations in the form of tablets for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations in the form of solutions for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations in the form of solutions for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations in the form of suspensions for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations in the form of suspensions for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Pharmaceutical formulations for intra-veneous application for treatment of infectious diseases, viral infections, herpes simplex virus infections, Pharmaceutical formulations for intra-veneous application for prophylaxis of infectious diseases, viral infections, herpes simplex virus infections; Antiviral drugs for treating of sexually transmittable diseases; Medicinal preparations for the treatment of sexually transmittable diseases.

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 5, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 12, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 26, 2025 FICS
FINAL DISPOSITION PROCESSED
Mar 26, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 22, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 22, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 22, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2024 TROA
REFUSAL PROCESSED BY IB
Jan 23, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 28, 2023 RFCS
REFUSAL PROCESSED BY MPU
Dec 28, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 20, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 19, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 19, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 27, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 23, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 22, 2023 REPR